Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)

NCT04389177 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Stage III

Interventions

DRUG: Pembrolizumab Injection [Keytruda]

Sponsor

Tianjin Medical University Cancer Institute and Hospital